Bruker BRKR
NASDAQ BRKR
$60.50 +1.85 (+3.15%)
At close: Aug 20, 2026 · 1:24 PM UTC

Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026)

Bruker's (BRKR) quarterly Net Income towards Common Stockholders came in at $3.5 million in Q1 2026, down 79.89% YoY from $17.4 million in Q1 2025, and down 76.51% on a QoQ basis from $14.9 million in Q4 2025.

Bruker (BRKR) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Bruker (BRKR) has 17 years of Net Income towards Common Stockholders data on file, last reported at $3.5 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders fell 79.89% year-over-year to $3.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.0 million (down 162.81% YoY) and the FY2025 annual result came in at -$22.5 million, down 119.89% from the prior year.
  • Net Income towards Common Stockholders slipped to $3.5 million in Q1 2026, from $14.9 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $205.5 million in Q4 2023 to a low of -$62.4 million in Q3 2025.
  • A 5-year average of $47.3 million and a median of $49.5 million in 2022 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2023 — Net Income towards Common Stockholders jumped 110.99% — and 2025, when it slumped 252.57%.
  • Tracing BRKR's Net Income towards Common Stockholders over 5 years: stood at $97.4 million in 2022, then jumped by 110.99% to $205.5 million in 2023, then plunged by 93.33% to $13.7 million in 2024, then grew by 8.76% to $14.9 million in 2025, then tumbled by 76.51% to $3.5 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at $3.5 million (Q1 2026), $14.9 million (Q4 2025), and -$62.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 199.07 Bn 193.46 Bn 7.27 Bn 928.00 Mn
2 Stryker 127.90 Bn 124.43 Bn 4.50 Bn 1.28 Bn
3 Medtronic 118.84 Bn 109.62 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 73.33 Bn 72.79 Bn 3.85 Bn 907.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn 241.40 Mn
6 Dexcom 34.46 Bn 32.51 Bn 830.00 Mn 249.10 Mn
7 GE HealthCare Technologies 33.91 Bn 31.81 Bn 2.18 Bn 574.00 Mn
8 Koninklijke Philips 26.36 Bn 23.04 Bn 4.55 Bn 621.86 Mn
9 Steris 23.12 Bn 22.64 Bn 684.20 Mn 201.00 Mn
10 Bruker 9.21 Bn 9.21 Bn 416.00 Mn -62.90 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -62.90 Mn
Mar 31, 2026 3.50 Mn
Dec 31, 2025 14.90 Mn
Sep 30, 2025 -62.40 Mn
Jun 30, 2025 -6.00 Mn
Mar 31, 2025 17.40 Mn
Dec 31, 2024 13.70 Mn
Sep 30, 2024 40.90 Mn
Jun 30, 2024 7.60 Mn
Mar 31, 2024 50.90 Mn
Dec 31, 2023 205.50 Mn
Sep 30, 2023 88.10 Mn
Jun 30, 2023 57.10 Mn
Mar 31, 2023 76.50 Mn
Dec 31, 2022 97.40 Mn
Sep 30, 2022 88.10 Mn
Jun 30, 2022 49.50 Mn
Mar 31, 2022 61.60 Mn
Dec 31, 2021 75.70 Mn
Sep 30, 2021 87.10 Mn